2010-12-04

To provide additional time for interaction, speakers from the following scientific sessions will remain after each session for an additional 30 minutes to answer questions: 

• Who Directs Lineage Fate? (Timm Schroeder, PhD; Pier Paolo Pandolfi, MD, PhD; Michael Sieweke, PhD)

•  Genome-Based Technology: Application to Human Disease (Eric Green, MD, PhD; Stuart Orkin, MD; David Ginsburg, MD)

•  Genetic and Epigenetic Regulation of Immune Responses (Laurie Glimcher, MD; Wayne Hancock, MD, PhD; Pavan Reddy, MD)

•  Epigenetic Regulation in Lymphoid Malignancies (Stephen Baylin, MD; Kapil Bhalla, MD; Susan Bates, MD)

•  Molecular Pathogenesis and Targeted Therapy in Myeloproliferative Neoplasia (William Vainchenker, MD, PhD; Richard Van Etten, MD, PhD; Ayalew Tefferi, MD)

•  Therapeutic Targeting of the Myeloma Stem Cell (William Matsui, MD; Alberto Orfao, MD, PhD; Constantine Mitsiades, MD, PhD)

•  Life Cycle of the Hematopoietic Stem Cell (Hanna Mikkola, MD, PhD; Douglas Hilton, PhD; Norman Iscove, MD, PhD)

•  Making Blood From Progenitors Ex Vivo (Anna Rita Migliaccio, PhD; Mortimer Poncz, MD; Helen Heslop, MD, PhD)

For more details, look for invited scientific program sessions marked with a double dagger (‡) in the Program Book.